Peter Marks (Greg Nash/Pool via AP)
Amid meddling concerns, FDA convenes adcomm for Pfizer/BioNTech booster
The FDA’s panel of outside vaccine advisors is set to meet in two weeks and discuss Pfizer and BioNTech’s sBLA application for a third, booster …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
